Literature DB >> 14562604

Progressive development of pulmonary hypertension leading to right ventricular hypertrophy assessed by echocardiography in rats.

Yosuke Kato1, Mitsunori Iwase, Hiroaki Kanazawa, Natsuki Kawata, Yukie Yoshimori, Katsunori Hashimoto, Toyoharu Yokoi, Akiko Noda, Kenzo Takagi, Yasuo Koike, Takao Nishizawa, Masahiko Nishimura, Mitsuhiro Yokota.   

Abstract

The present study aimed to evaluate the development of pulmonary hypertension by serial echocardiography, including measurements of pulmonary artery (PA) flow velocities, and correlate echocardiographic indices with pathological findings in rats administered monocrotaline (MCT). MCT (60 mg/kg body weight) or physiologic saline was administered to a total of 9 male Wistar rats at the age of 4 weeks (MCT group: n = 4, control group: n = 5, respectively). Echocardiography was performed serially until the age of 8 weeks. The ratio of right ventricular (RV) outflow tract dimensions to aortic dimensions increased progressively in the MCT group and became significantly greater than that of the control group after the age of 6 weeks. Peak PA velocity (Peak V) in the MCT group was significantly less than that of the control group at the ages of 7 and 8 weeks. The ratio of acceleration time to ejection time (AT/ET) in PA flow waveforms declined progressively and was significantly less than that of the control group after the age of 6 weeks. The ratio of RV weight to body weight (RVW/BW) in the MCT group was significantly greater than that of the control group. Both AT/ET ratio and Peak V were significantly inversely correlated with RVW/BW ratio. Furthermore, these echocardiographic findings were also significantly inversely correlated with the mean cross-sectional RV myocyte area. In conclusion, the progressive development of pulmonary hypertension leading to RV hypertrophy can be evaluated appropriately by echocardiography including PA flow Doppler indices in rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14562604     DOI: 10.1538/expanim.52.285

Source DB:  PubMed          Journal:  Exp Anim        ISSN: 0007-5124


  9 in total

1.  Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model.

Authors:  Fuminobu Ishikura; Ryoko Azakami; Toshihiko Asanuma; Shintaro Beppu
Journal:  J Med Ultrason (2001)       Date:  2012-05-24       Impact factor: 1.314

2.  Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.

Authors:  Dalia Urboniene; Idith Haber; Yong-Hu Fang; Thenappan Thenappan; Stephen L Archer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

3.  Contribution of oxidative stress to pulmonary arterial hypertension.

Authors:  Vincent G Demarco; Adam T Whaley-Connell; James R Sowers; Javad Habibi; Kevin C Dellsperger
Journal:  World J Cardiol       Date:  2010-10-26

4.  Beneficial effects of fenofibrate in pulmonary hypertension in rats.

Authors:  Palak Galhotra; Pankaj Prabhakar; Himanshu Meghwani; Soheb A Mohammed; Sanjay Kumar Banerjee; Sandeep Seth; Milind P Hote; K H Reeta; Ruma Ray; Subir Kumar Maulik
Journal:  Mol Cell Biochem       Date:  2018-05-14       Impact factor: 3.396

5.  Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats.

Authors:  Himanshu Meghwani; Pankaj Prabhakar; Soheb A Mohammed; Pamila Dua; Sandeep Seth; Milind P Hote; Sanjay K Banerjee; Sudheer Arava; Ruma Ray; Subir Kumar Maulik
Journal:  Medicines (Basel)       Date:  2018-04-17

6.  Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.

Authors:  Akira Sugiyama; Maina Kaisho; Muneyoshi Okada; Kosuke Otani; Hideyuki Yamawaki
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

7.  Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

Authors:  Rio Dumitrascu; Silke Koebrich; Eva Dony; Norbert Weissmann; Rajkumar Savai; Soni S Pullamsetti; Hossein A Ghofrani; Arun Samidurai; Horst Traupe; Werner Seeger; Friedrich Grimminger; Ralph T Schermuly
Journal:  BMC Pulm Med       Date:  2008-12-17       Impact factor: 3.317

8.  Novel Model of Pulmonary Artery Banding Leading to Right Heart Failure in Rats.

Authors:  Masataka Hirata; Daiki Ousaka; Sadahiko Arai; Michihiro Okuyama; Suguru Tarui; Junko Kobayashi; Shingo Kasahara; Shunji Sano
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

9.  Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do.

Authors:  Xiaoqing Yin; Lu Wang; Gang Qin; Hui Luo; Xiao Liu; Fan Zhang; Zhi Ye; Junjie Zhang; E Wang
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.